16 February 2016
("Instem" or the "Company")
Instem plc (AIM: INS), a leading provider of IT solutions to the global early development healthcare market, announces that it will be presenting at the Shares Investor Evening in Edinburgh.
The event will commence at 6.00pm at the Radisson Blu Hotel, 80 High Street, The Royal Mile, Edinburgh, EH1 1TH, on Thursday 25 February 2016.
CEO Phil Reason and CFO Nigel Goldsmith will deliver a presentation detailing the Company’s strategy followed by a Q&A session.
Copies of the presentation will also be available on the Company’s website following the event.
No new material information will be disclosed during the course of the event.
Investors can register for the event by clicking the link below:
For further information, please contact:
|Phil Reason, CEO||+44 (0) 1785 825600|
|Nigel Goldsmith, CFO|
|N+1 Singer (Nominated Adviser & Broker)||+44 (0) 20 7496 3000|
|Wallbrook Financial PR||Tel: +44 (0) 20 7933 8000|
|Paul Cornelius||or firstname.lastname@example.org|
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidlyexpanding needs of life science and healthcare organisations for data-driven decision making leading to safer, more effective products.
Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.
Instem supports over 450 clients through full service offices in the United States, United Kingdom and China with additional locations in Japan and India.
To learn more about Instem solutions and its mission, please visit instem.com.